Advos

American Shared Hospital Services will report first quarter 2026 financial results on May 14, with a conference call to discuss the results at 12:00 pm ET.

Auddia Inc. showcases Influence Healthcare, an AI-driven specialty care platform that empowers surgeons to lead value-based care, as it prepares to file its S-4 registration for a merger that will create McCarthy Finney.

Aemetis announced first quarter 2026 revenues of $54.6 million, a 27% increase year-over-year, with gross profit turning positive and dairy RNG sales up 55%.

Aclarion, Inc. announced the addition of Lanman Spinal Neurosurgery, a private practice in Beverly Hills, to its CLARITY trial, which tests Nociscan's ability to improve surgical outcomes for chronic low back pain by precisely identifying pain-generating discs.

SS Innovations successfully performed a long-distance telesurgery using its SSi Mantra system, connecting a surgeon in Australia to a patient in India, demonstrating the potential to democratize access to surgical expertise.

A systematic review in JAMA Network Open suggests that earlier administration of immune checkpoint inhibitors could improve survival in patients with late-stage solid tumors, though prospective studies are needed before clinical adoption.

Apple has agreed to a $250 million settlement in a lawsuit alleging it misled customers about the capabilities of its Apple Intelligence features.

SKYX Platforms Corp. announced record Q1 2026 revenue of $22 million, a 10% YoY increase, driven by strategic partnerships and expansion into European and U.S. smart city projects.

Oregen Energy Corp. hired Philip Birch, a petroleum geoscientist who helped identify the Venus prospect, as strategic advisor to evaluate a potential investment in Namibia's offshore Block 2812Ab adjacent to a major discovery.

Planet Ventures Inc. is investing in space-based energy infrastructure to address growing power demands from satellites, AI workloads, and space-based data centers.

SureNano Science Ltd. has initiated an FDA-aligned GLP toxicology and pharmacology program for its lead candidate GEP-44, targeting the rapidly growing GLP-1 market for obesity and type 2 diabetes, with potential to support a Phase I clinical trial in Australia.

Oncotelic Therapeutics is utilizing a partnership-driven approach, including a joint venture that added $249 million to its balance sheet, to advance its pipeline without diluting shareholder value.

Greenland Energy Company (NASDAQ: GLND) is focusing on Greenland’s Jameson Land Basin to develop new hydrocarbon resources amid global supply constraints and geopolitical instability.

Pershing Square USA and Pershing Square Inc. completed combined IPOs and private placements, generating $5 billion in gross proceeds for PSUS, marking a significant capital raise for the investment firm.

Delta Gold Technologies PLC is featured in the first episode of The Innovation Report Series, which explores the commercial potential and industry impact of quantum technologies.